The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Open accessAbstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease, the main pathological hallmark of which is the accumulation of α-synuclein (α-syn) and the formation of filamentous aggregates called Lewy bodies in the brainstem, limbic system, and cortical areas. Lipidomics is a newly emerging field which can provide fresh insights and new answers that will enhance our capacity for early diagnosis, tracking disease progression, predicting critical endpoints, and identifying risk in pre-symptomatic persons. In recent years, lipids have been implicated in many aspects of PD pathology. Biophysical and lipidomic studies have demonstrated that α-syn binds preferentially not only to specific lipid families but also to specific molecular species and that these lipid-protein complexes enhance its interaction with synaptic membranes, influence its oligomerization and aggregation, and interfere with the catalytic activity of cytoplasmic lipid enzymes and lysosomal lipases, thereby affecting lipid metabolism. The genetic link between aberrant lipid metabolism and PD is even more direct, with mutations in GBA and SMPD1 enhancing PD risk in humans and loss of GALC function increasing α-syn aggregation and accumulation in experimental murine models. Moreover, a number of lipidomic studies have reported PD-specific lipid alterations in both patient brains and plasma, including alterations in the lipid composition of lipid rafts in the frontal cortex. A further aspect of lipid dysregulation promoting PD pathogenesis is oxidative stress and inflammation, with proinflammatory lipid mediators such as platelet activating factors (PAFs) playing key roles in arbitrating the progressive neurodegeneration seen in PD linked to α-syn intracellular trafficking. Lastly, there are a number of genetic risk factors of PD which are involved in normal lipid metabolism and function. Genes such as PLA2G6 and SCARB2, which are involved in glycerophospholipid and sphingolipid metabolism either directly or indirectly are associated with risk of PD. This review seeks to describe these facets of metabolic lipid dysregulation as they relate to PD pathology and potential pathomechanisms involved in disease progression, while highlighting incongruous findings and gaps in knowledge that necessitate further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wislet‐Gendebien, S., Visanji, N. P., Whitehead, S. N., Marsilio, D., Hou, W., Figeys, D., Fraser, P. E., Bennett, S. A. L., & Tandon, A. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-92 · Cited by 26
Self-citationRetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“According to the Braak staging scheme, the temporal mesocortex and neocortex, along with distinct areas of the brainstem, become progressively involved over time, with the substantia nigra (SN) being severely affected by stage 4 as well as some effects on the amygdala, while at stage 5 the anterior cingulate cortex (A…”
MethodBernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Anderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,416
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Lipid rafts: bringing order to chaos
Pike, L. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200021-jlr200 · Cited by 1,138
Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,056
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Lipid raft microdomains and neurotransmitter signalling
Allen, J. A., Halverson-Tamboli, R. A., & Rasenick, M. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2059 · Cited by 852
George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844
Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Colley, W. C., Sung, T.-C., Roll, R., Jenco, J., Hammond, S. M., Altshuller, Y., Bar-Sagi, D., Morris, A. J., & Frohman, M. A. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70090-3 · Cited by 698
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease
Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696
Disturbed mitochondrial dynamics and neurodegenerative disorders
Burté, F., Carelli, V., Chinnery, P. F., & Yu-Wai-Man, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 660
Hammond, S. M., Altshuller, Y. M., Sung, T.-C., Rudge, S. A., Rose, K., Engebrecht, J., Morris, A. J., & Frohman, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29640 · Cited by 658
Neuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van der Putten, H., Probst, A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06365.2000 · Cited by 641
Inflammation and neurodegeneration in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 625
α-Synuclein Membrane Interactions and Lipid Specificity
Jo, E., McLaurin, J., Yip, C. M., St. George-Hyslop, P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004345200 · Cited by 604
A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 1×
“…control of neurotransmitter release (Abeliovich et al., 2000; Gureviciene et al., 2007; Nemani et al., 2010; Tsigelny et al., 2012; Wang et al., 2016), as well as modulating dopamine biosynthesis (Perez et al., 2002; Sidhu et al., 2004) and transport (Lee et al., 2001; Wersinger and Sidhu, 2003).”
BackgroundNakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L., Zhang, J., Gardner, B., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 596
The link between the GBA gene and parkinsonism
Sidransky, E., & Lopez, G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70190-4 · Cited by 583
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Gegg, M. E., Burke, D., Heales, S. J. R., Cooper, J. M., Hardy, J., Wood, N. W., & Schapira, A. H. V. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 564
Sharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00024-2 · Cited by 562
GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease
Yanagisawa, K., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Nature Medicine · doi:10.1038/nm1095-1062 · Cited by 550
Schöndorf, D. C., Aureli, M., McAllister, F. E., Hindley, C. J., Mayer, F., Schmid, B., Sardi, S. P., Valsecchi, M., Hoffmann, S., Schwarz, L. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms5028 · Cited by 543
Characterization of Two Alternately Spliced Forms of Phospholipase D1
Hammond, S. M., Jenco, J. M., Nakashima, S., Cadwallader, K., Gu, Q.-M., Cook, S., Nozawa, Y., Prestwich, G. D., Frohman, M. A., & Morris, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3860 · Cited by 541
Schmidt, A., Wolde, M., Thiele, C., Fest, W., Kratzin, H., Podtelejnikov, A. V., Witke, W., Huttner, W. B., & Söling, H.-D. (1999) · Nature · doi:10.1038/43613 · Cited by 533
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Fusco, G., De Simone, A., Gopinath, T., Vostrikov, V., Vendruscolo, M., Dobson, C. M., & Veglia, G. (2014) · Nature Communications · doi:10.1038/ncomms4827 · Cited by 528
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524
Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease
BEAL, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523
Lipid Rafts Mediate the Synaptic Localization of α-Synuclein
Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S.-I., Anthony, M. D., & Edwards, R. H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1594-04.2004 · Cited by 518
Do, C. B., Tung, J. Y., Dorfman, E., Kiefer, A. K., Drabant, E. M., Francke, U., Mountain, J. L., Goldman, S. M., Tanner, C. M., Langston, J. W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002141 · Cited by 515
α-Synuclein Is Localized to Mitochondria-Associated ER Membranes
Guardia-Laguarta, C., Area-Gomez, E., Rüb, C., Liu, Y., Magrané, J., Becker, D., Voos, W., Schon, E. A., & Przedborski, S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2507-13.2014 · Cited by 515
The Aggregation and Fibrillation of α-Synuclein
Fink, A. L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050073t · Cited by 501
Pike, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800040-jlr200 · Cited by 493
Chain length-specific properties of ceramides
Grösch, S., Schiffmann, S., & Geisslinger, G. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.001 · Cited by 483
Characterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1
Kamp, F., Exner, N., Lutz, A. K., Wender, N., Hegermann, J., Brunner, B., Nuscher, B., Bartels, T., Giese, A., Beyer, K., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.223 · Cited by 479
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475 · cited 1×
“Moreover, it is only the moderate reductions (as are seen in PD and DLB,) and not the severe reductions in GCase activity (as are observed Gaucher disease), that increase α-syn levels in vitro as detected in post-mortem PD brain tissue (Murphy et al., 2014; Kim et al., 2018).”
BackgroundThe A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
LEE, F. J. S., LIU, F., PRISTUPA, Z. B., & NIZNIK, H. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0334com · Cited by 455
Pathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 443
Jenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431
Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein α-Synuclein
Cole, N. B., Murphy, D. D., Grider, T., Rueter, S., Brasaemle, D., & Nussbaum, R. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108414200 · Cited by 430
Diacylglycerol kinases: at the hub of cell signalling
Mérida, I., Ávila-Flores, A., & Merino, E. (2008) · Biochemical Journal · doi:10.1042/bj20071040 · Cited by 427
Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein
Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L., & Muchowski, P. J. (2003) · Science · doi:10.1126/science.1090389 · Cited by 422 · cited 1×
“Willingham et al. (2003) conducted a genome-wine screening study in yeast which supports the involvement of lipid metabolism in α-syn toxicity.”
BackgroundGlucocerebrosidase activity in Parkinson’s disease with and without GBA mutations
Alcalay, R. N., Levy, O. A., Waters, C. H., Fahn, S., Ford, B., Kuo, S.-H., Mazzoni, P., Pauciulo, M. W., Nichols, W. C., Gan-Or, Z., et al. (2015) · Brain · doi:10.1093/brain/awv179 · Cited by 392
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Kalia, L. V., Lang, A. E., Hazrati, L.-N., Fujioka, S., Wszolek, Z. K., Dickson, D. W., Ross, O. A., Van Deerlin, V. M., Trojanowski, J. Q., Hurtig, H. I., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2704 · Cited by 384
Mechanism of 6-hydroxydopamine neurotoxicity
Glinka, Y., Gassen, M., & Youdim, M. B. H. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_7 · Cited by 380
Fabelo, N., Martín, V., Santpere, G., Marín, R., Torrent, L., Ferrer, I., & Díaz, M. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00119 · Cited by 379
Acceleration of α-Synuclein Aggregation by Exosomes
Grey, M., Dunning, C. J., Gaspar, R., Grey, C., Brundin, P., Sparr, E., & Linse, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.585703 · Cited by 377
Multiple Tight Phospholipid-Binding Modes of α-Synuclein Revealed by Solution NMR Spectroscopy
Bodner, C. R., Dobson, C. M., & Bax, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.05.066 · Cited by 376
Poirier, J., Baccichet, A., Dea, D., & Gauthier, S. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90456-p · Cited by 329
Sharon, R., Goldberg, M. S., Bar-Josef, I., Betensky, R. A., Shen, J., & Selkoe, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171300598 · Cited by 328
Role of cholesterol in synapse formation and function
Pfrieger, F. W. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00024-5 · Cited by 325
Zhu, M., Li, J., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305326200 · Cited by 323
Sardi, S. P., Clarke, J., Kinnecom, C., Tamsett, T. J., Li, L., Stanek, L. M., Passini, M. A., Grabowski, G. A., Schlossmacher, M. G., Sidman, R. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108197108 · Cited by 319
Lipid Binding Inhibits α-Synuclein Fibril Formation
Zhu, M., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210136200 · Cited by 314
Galvagnion, C., Brown, J. W. P., Ouberai, M. M., Flagmeier, P., Vendruscolo, M., Buell, A. K., Sparr, E., & Dobson, C. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601899113 · Cited by 308
Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
The Effect of GTPase Activating Protein Upon Ras Is Inhibited by Mitogenically Responsive Lipids
Tsai, M.-H., Yu, C.-L., Wei, F.-S., & Stacey, D. W. (1989) · Science · doi:10.1126/science.2536192 · Cited by 284
Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins
Perrin, R. J., Woods, W. S., Clayton, D. F., & George, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105022200 · Cited by 279
GBA-associated PD presents with nonmotor characteristics
Brockmann, K., Srulijes, K., Hauser, A.-K., Schulte, C., Csoti, I., Gasser, T., & Berg, D. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab77 · Cited by 268
GM1 Specifically Interacts with α-Synuclein and Inhibits Fibrillation
Martinez, Z., Zhu, M., Han, S., & Fink, A. L. (2007) · Biochemistry · doi:10.1021/bi061749a · Cited by 260
Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking α-Synuclein
Ellis, C. E., Murphy, E. J., Mitchell, D. C., Golovko, M. Y., Scaglia, F., Barceló-Coblijn, G. C., & Nussbaum, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10190-10201.2005 · Cited by 260
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260
The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson’s Disease
Galvagnion, C. (2017) · Journal of Parkinson's Disease · doi:10.3233/jpd-171103 · Cited by 258
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
Seet, R. C. S., Lee, C.-Y. J., Lim, E. C. H., Tan, J. J. H., Quek, A. M. L., Chong, W.-L., Looi, W.-F., Huang, S.-H., Wang, H., Chan, Y.-H., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.026 · Cited by 257
Docosahexaenoic Acid and the Aging Brain
Lukiw, W. J., & Bazan, N. G. (2008) · The Journal of Nutrition · doi:10.3945/jn.108.096016 · Cited by 247
Singer, T. P., Castagnoli, N., Ramsay, R. R., & Trevor, A. J. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03384.x · Cited by 244
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Taguchi, Y. V., Liu, J., Ruan, J., Pacheco, J., Zhang, X., Abbasi, J., Keutzer, J., Mistry, P. K., & Chandra, S. S. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1525-17.2017 · Cited by 243
A Seed for Alzheimer Amyloid in the Brain
Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0861-04.2004 · Cited by 239
Mielke, M. M., Maetzler, W., Haughey, N. J., Bandaru, V. V. R., Savica, R., Deuschle, C., Gasser, T., Hauser, A.-K., Gräber-Sultan, S., Schleicher, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073094 · Cited by 232
Alpha-synuclein, lipids and Parkinson’s disease
Ruipérez, V., Darios, F., & Davletov, B. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.004 · Cited by 231
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Simon, K. C., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000271883.45010.8a · Cited by 231
Animal models of Parkinson’s disease progression
Meredith, G. E., Sonsalla, P. K., & Chesselet, M.-F. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0350-x · Cited by 228
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226
The UK Parkinson's Disease Consortium and The Wellcome Trust Case Control Consortium 2, Spencer, C. C. A., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Band, G., Barker, R. A., Bellenguez, C., Bhatia, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq469 · Cited by 219
Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
Maltsev, A. S., Ying, J., & Bax, A. (2012) · Biochemistry · doi:10.1021/bi300642h · Cited by 219
Nakamura, K., Nemani, V. M., Wallender, E. K., Kaehlcke, K., Ott, M., & Edwards, R. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3088-08.2008 · Cited by 210
Total cholesterol and the risk of Parkinson disease
Hu, G., Antikainen, R., Jousilahti, P., Kivipelto, M., & Tuomilehto, J. (2008) · Neurology · doi:10.1212/01.wnl.0000312511.62699.a8 · Cited by 206
Serum Cholesterol Levels and the Risk of Parkinson's Disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj283 · Cited by 205
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models
Sardi, S. P., Viel, C., Clarke, J., Treleaven, C. M., Richards, A. M., Park, H., Olszewski, M. A., Dodge, J. C., Marshall, J., Makino, E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616152114 · Cited by 203
Glia‐derived signals induce synapse formation in neurones of the rat central nervous system
Nägler, K., Mauch, D. H., & Pfrieger, F. W. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00665.x · Cited by 203
Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein
Ryan, T., Bamm, V. V., Stykel, M. G., Coackley, C. L., Humphries, K. M., Jamieson-Williams, R., Ambasudhan, R., Mosser, D. D., Lipton, S. A., Harauz, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03241-9 · Cited by 202
Cellular Responses to Excess Phospholipid
Baburina, I., & Jackowski, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9400 · Cited by 197
Attenuation of dopamine transporter activity by α-synuclein
Wersinger, C., & Sidhu, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00097-1 · Cited by 197
Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction
Kinghorn, K. J., Castillo-Quan, J. I., Bartolome, F., Angelova, P. R., Li, L., Pope, S., Cochemé, H. M., Khan, S., Asghari, S., Bhatia, K. P., et al. (2015) · Brain · doi:10.1093/brain/awv132 · Cited by 197
Ktistakis, N. T., Brown, H. A., Sternweis, P. C., & Roth, M. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4952 · Cited by 195
Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex
Cheng, D., Jenner, A. M., Shui, G., Cheong, W. F., Mitchell, T. W., Nealon, J. R., Kim, W. S., McCann, H., Wenk, M. R., Halliday, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017299 · Cited by 189
Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Ludtmann, M. H. R., Angelova, P. R., Ninkina, N. N., Gandhi, S., Buchman, V. L., & Abramov, A. Y. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1659-16.2016 · Cited by 189
Dikiy, I., & Eliezer, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512459 · Cited by 188
Sharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309127200 · Cited by 187
Mitochondrial translocation of α-synuclein is promoted by intracellular acidification
Cole, N. B., DiEuliis, D., Leo, P., Mitchell, D. C., & Nussbaum, R. L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.012 · Cited by 185
Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients: A Case-Control Study
Scigliano, G., Musicco, M., Soliveri, P., Piccolo, I., Ronchetti, G., & Girotti, F. (2006) · Stroke · doi:10.1161/01.str.0000217384.03237.9c · Cited by 182
Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients
Parnetti, L., Paciotti, S., Eusebi, P., Dardis, A., Zampieri, S., Chiasserini, D., Tasegian, A., Tambasco, N., Bembi, B., Calabresi, P., et al. (2017) · Movement Disorders · doi:10.1002/mds.27136 · Cited by 178
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
Gan-Or, Z., Ozelius, L. J., Bar-Shira, A., Saunders-Pullman, R., Mirelman, A., Kornreich, R., Gana-Weisz, M., Raymond, D., Rozenkrantz, L., Deik, A., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f180e · Cited by 175
Blood-based biomarkers for Parkinson's disease
Chahine, L. M., Stern, M. B., & Chen‐Plotkin, A. S. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70025-7 · Cited by 172
Regulation of brain polyunsaturated fatty acid uptake and turnover
Chen, C. T., Green, J. T., Orr, S. K., & Bazinet, R. P. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.003 · Cited by 171
Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation
Tsigelny, I. F., Sharikov, Y., Wrasidlo, W., Gonzalez, T., Desplats, P. A., Crews, L., Spencer, B., & Masliah, E. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08489.x · Cited by 170
Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease
Farooqui, T., & Farooqui, A. A. (2011) · Parkinson s Disease · doi:10.4061/2011/247467 · Cited by 170
Sidhu, A., Wersinger, C., & Vernier, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.063 · Cited by 170
Hsu, L. J., Mallory, M., Xia, Y., Veinbergs, I., Hashimoto, M., Yoshimoto, M., Thal, L. J., Saitoh, T., & Masliah, E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010338.x · Cited by 170
Fauvet, B., Fares, M.-B., Samuel, F., Dikiy, I., Tandon, A., Eliezer, D., & Lashuel, H. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383711 · Cited by 169
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
Wu, G., Lu, Z., Kulkarni, N., & Ledeen, R. W. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23090 · Cited by 167
Phenotypic spectrum of patients with PLA2G6 mutation and PARK14 -linked parkinsonism
Yoshino, H., Tomiyama, H., Tachibana, N., Ogaki, K., Li, Y., Funayama, M., Hashimoto, T., Takashima, S., & Hattori, N. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f73649 · Cited by 165
α-Synuclein Expression Modulates Microglial Activation Phenotype
Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 165
Walker, D. G., Lue, L., Adler, C. H., Shill, H. A., Caviness, J. N., Sabbagh, M. N., Akiyama, H., Serrano, G. E., Sue, L. I., & Beach, T. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.020 · Cited by 165
Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
Abbott, S. K., Li, H., Muñoz, S. S., Knoch, B., Batterham, M. J., Murphy, K. E., Halliday, G. M., & Garner, B. (2013) · Movement Disorders · doi:10.1002/mds.25729 · Cited by 162
Functional Mitochondria Are Required for α-Synuclein Toxicity in Aging Yeast
Büttner, S., Bitto, A., Ring, J., Augsten, M., Zabrocki, P., Eisenberg, T., Jungwirth, H., Hütter, S., Carmona‐Gutiérrez, D., Kroemer, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708477200 · Cited by 161
Membrane Interaction of α-Synuclein in Different Aggregation States
Grey, M., Linse, S. S., Nilsson, H., Brundin, P., & Sparr, E. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11067 · Cited by 160
Exploring the link between glucocerebrosidase mutations and parkinsonism
Westbroek, W., Gustafson, A. M., & Sidransky, E. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.003 · Cited by 160
Rosenbloom, B., Balwani, M., Bronstein, J. M., Kolodny, E., Sathe, S., Gwosdow, A. R., Taylor, J. S., Cole, J. A., Zimran, A., & Weinreb, N. J. (2011) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2010.10.006 · Cited by 158
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
Tsuang, D. W., Leverenz, J. B., López, O. L., Hamilton, R. L., Bennett, D. A., Schneider, J. A., Buchman, A. S., Larson, E. B., Crane, P. K., Kaye, J. A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182735e9a · Cited by 156
No evidence for substrate accumulation in Parkinson brains with GBA mutations
Gegg, M. E., Sweet, L., Wang, B. H., Shihabuddin, L. S., Sardi, S. P., & Schapira, A. H. V. (2015) · Movement Disorders · doi:10.1002/mds.26278 · Cited by 154
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 154
Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7929 · Cited by 151
Phosphatidate-dependent protein phosphorylation.
Bocckino, S. B., Wilson, P. B., & Exton, J. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6210 · Cited by 150
Brás, J., Singleton, A., Cookson, M., & Hardy, J. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06709.x · Cited by 145
Schneider, J. S., Gollomp, S. M., Sendek, S., Colcher, A., Cambi, F., & Du, W. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.10.024 · Cited by 143
Manev, H., Favaron, M., Vicini, S., Guidotti, A., & Costa, E. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13364-8 · Cited by 143
The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases
Ben‐David, O., & Futerman, A. H. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8114-x · Cited by 140
Multi-organ autonomic dysfunction in Parkinson disease
Jain, S. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.022 · Cited by 140
Xu, Y. H., Sun, Y., Ran, H., Quinn, B., Witte, D. P., & Grabowski, G. A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.12.014 · Cited by 139
GM1 ganglioside in Parkinson's disease: Results of a five year open study
Schneider, J. S., Sendek, S., Daskalakis, C., & Cambi, F. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.02.009 · Cited by 139
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0 · Cited by 136
Beranová, L., Cwiklik, L., Jurkiewicz, P., Hof, M., & Jungwirth, P. (2010) · Langmuir · doi:10.1021/la100657a · Cited by 135
Updates on immunity and inflammation in Parkinson disease pathology
Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 134
Ambrosio, G., Oriente, A., Claudio Napoli, A., Palumbo, G. A., Chiariello, P., Marone, G., Condorelli, M., Chiariello, M., & Triggiani, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117248 · Cited by 133
Statin use and the risk of Parkinson disease
Wahner, A. D., Bronstein, J. M., Bordelon, Y. M., & Ritz, B. R. (2008) · Neurology · doi:10.1212/01.wnl.0000286942.14552.51 · Cited by 132
Ivatt, R. M., Sanchez-Martinez, A., Godena, V. K., Brown, S., Ziviani, E., & Whitworth, A. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321207111 · Cited by 130
Mice Deficient in Group IV Cytosolic Phospholipase A2 Are Resistant to MPTP Neurotoxicity
Klivènyi, P., Beal, M. F., Ferrante, R. J., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062634.x · Cited by 129
Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort study
Rozani, V., Gurevich, T., Giladi, N., El‐Ad, B., Tsamir, J., Hemo, B., & Peretz, C. (2018) · Movement Disorders · doi:10.1002/mds.27413 · Cited by 129
Golovko, M. Y., Færgeman, N. J., Cole, N. B., Castagnet, P. I., Nussbaum, R. L., & Murphy, E. J. (2005) · Biochemistry · doi:10.1021/bi0502137 · Cited by 125
Fatty acid incorporation is decreased in astrocytes cultured from α‐synuclein gene‐ablated mice
Castagnet, P. I., Golovko, M. Y., Barceló‐Coblijn, G., Nussbaum, R. L., & Murphy, E. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03247.x · Cited by 124
Huang, X., Abbott, R. D., Petrovitch, H., Mailman, R. B., & Ross, G. W. (2008) · Movement Disorders · doi:10.1002/mds.22013 · Cited by 124
Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 123
Versatile Structures of α-Synuclein
Wang, C., Zhao, C., Li, D., Tian, Z., Lai, Y., Diao, J., & Liu, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00048 · Cited by 123
Gaucher disease: insights from a rare Mendelian disorder.
Sidransky, E. (2012) · PubMed · Cited by 121
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation
Bae, E.-J., Yang, N. Y., Lee, C.-S., Lee, H.-J., Kim, S., Sardi, S. P., & Lee, S. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.128 · Cited by 121
Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice
Barceló‐Coblijn, G., Golovko, M. Y., Weinhofer, I., Berger, J., & Murphy, E. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04348.x · Cited by 119
Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease
Markopoulou, K., Dickson, D. W., McComb, R. D., Wszołek, Z. K., Katechalidou, L., Avery, L. L., Stansbury, M. S., & Chase, B. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0372-4 · Cited by 117
Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue
Hamano, K., Hayashi, M., Shioda, K., Fukatsu, R., & Mizutani, S. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0325-3 · Cited by 117
Taschenberger, G., Garrido, M., Tereshchenko, Y., Bähr, M., Zweckstetter, M., & Kügler, S. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0926-8 · Cited by 117
Abnormal α-Synuclein Interactions with Rab Proteins in α-Synuclein A30P Transgenic Mice
Dalfó, E., Gómez‐Isla, T., Rosa, J. L., Bodelón, M. N., Tejedor, M. C., Barrachina, M., Ambrosio, S., & Ferrer, I. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.302 · Cited by 115
Polyunsaturated Fatty Acids Induce α-Synuclein-Related Pathogenic Changes in Neuronal Cells
Assayag, K., Yakunin, E., Loeb, V., Selkoe, D. J., & Sharon, R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070373 · Cited by 114
Franceschi, G. D., Frare, E., Pivato, M., Relini, A., Penco, A., Greggio, E., Bubacco, L., Fontana, A., & de Laureto, P. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202937 · Cited by 113
Alpha‐Synuclein Binds to the Inner Membrane of Mitochondria in an α‐Helical Conformation
Robotta, M., Gerding, H. R., Vogel, A., Hauser, K., Schildknecht, S., Karreman, C., Leist, M., Subramaniam, V., & Drescher, M. (2014) · ChemBioChem · doi:10.1002/cbic.201402281 · Cited by 109
Zhao, Z., Shen, S. H., & Fischer, E. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4251 · Cited by 107
Elevated GM3 plasma concentration in idiopathic Parkinson’s disease: A lipidomic analysis
Chan, R., Perotte, A., Zhou, B., Liong, C., Shorr, E., Marder, K. S., Kang, U. J., Waters, C., Levy, O. A., Xu, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172348 · Cited by 106
Wang, S., Zhang, S., Liou, L.-C., Ren, Q., Zhang, Z., Caldwell, G. A., Caldwell, K. A., & Witt, S. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411694111 · Cited by 104
Interaction of α-synuclein with vesicles that mimic mitochondrial membranes
Zigoneanu, I. G., Yang, Y. J., Krois, A. S., Haque, M. E., & Pielak, G. J. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.11.024 · Cited by 104
Broersen, K., van den Brink, D. M., Fraser, G. M., Goedert, M., & Davletov, B. A. (2006) · Biochemistry · doi:10.1021/bi061743l · Cited by 103
Suzuki, M., Fujikake, N., Takeuchi, T., Kohyama‐Koganeya, A., Nakajima, K., Hirabayashi, Y., Wada, K., & Nagai, Y. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv372 · Cited by 102
Interaction of α-synuclein with biomembranes in Parkinson's disease —role of cardiolipin
Ghio, S., Kamp, F., Cauchi, R. J., Giese, A., & Vassallo, N. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.10.005 · Cited by 101
Role of α-synuclein in synaptic glutamate release
Gureviciene, I., Gurevicius, K., & Tanila, H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.016 · Cited by 99
Structural Determinants of PLD2 Inhibition by α-Synuclein
Payton, J. E., Perrin, R. J., Woods, W. S., & George, J. M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.014 · Cited by 99
Serum lipid alterations in GBA-associated Parkinson's disease
Guedes, L. C., Chan, R., Gomes, M. A., Conceição, V. A., Machado, R. B., Soares, T., Xu, Y., Gaspar, P., Carriço, J. A., Alcalay, R. N., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.08.026 · Cited by 98
O’Leary, E. I., Jiang, Z., Strub, M., & Lee, J. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002780 · Cited by 97
Mitochondrial lipids in neurodegeneration
Aufschnaiter, A., Kohler, V., Diessl, J., Peselj, C., Carmona‐Gutiérrez, D., Keller, W., & Büttner, S. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2463-1 · Cited by 95
VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease
Ramírez, C. M., González‐Gómez, M., Díaz, M. L., Alonso, R., Ferrer, I., Santpere, G., Puig, B., Meyer, G., & Marín, R. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.07.001 · Cited by 93
R632W mutation in PLA2G6 segregates with dystonia‐parkinsonism in a consanguineous Iranian family
Sina, F., Shojaee, S. M., Elahi, E., & Paisán‐Ruiz, C. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02356.x · Cited by 93
Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2
Barbour, S. E., Kapur, A., & Deal, C. L. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00078-5 · Cited by 91
Selective activation of phospholipase D2 by unsaturated fatty acid
Kim, J. H., Kim, Y. D., Lee, S. D., López, I., Arnold, R. S., Lambeth, J. D., Suh, P., & Ryu, S. H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00745-0 · Cited by 91
Cheng, H., Xu, J., McKeel, D. W., & Han, X. (2003) · PubMed · Cited by 90
The Antiarrhythmic and Anticonvulsant Effects of Dietary N-3 Fatty Acids
Leaf, A., Kang, J. X., Xiao, Y. F., Billman, G. E., & Voskuyl, R. A. (1999) · The Journal of Membrane Biology · doi:10.1007/s002329900578 · Cited by 89
Golovko, M. Y., Barceló‐Coblijn, G., Castagnet, P. I., Austin, S. A., Combs, C. K., & Murphy, E. J. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-0008-y · Cited by 88
Marín, R., Ramírez, C. M., Marin, R., Ramírez, C. M., González‐Gómez, M., González-Muñoz, E., Antonio Zorzano, A., Camps, M., Alonso, R., & Díaz, M. L. (2007) · Molecular Membrane Biology · doi:10.1080/09687860601055559 · Cited by 86
Golovko, M. Y., Rosenberger, T. A., Færgeman, N. J., Feddersen, S., Cole, N. B., Pribill, I., Berger, J., Nussbaum, R. L., & Murphy, E. J. (2006) · Biochemistry · doi:10.1021/bi0600289 · Cited by 85
Augmented frontal cortex diacylglycerol levels in Parkinson’s disease and Lewy Body Disease
Wood, P. L., Tippireddy, S., Feriante, J., & Woltjer, R. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191815 · Cited by 84
Hoshino, T., Mahmood, M. I., Mori, K., & Matsuzaki, K. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4029062 · Cited by 83
Lei, X., Zhang, S., Bohrer, A., Bao, S. S., Song, H., & Ramanadham, S. (2007) · Biochemistry · doi:10.1021/bi700017z · Cited by 83
Neuronal and glial accumulation of α- and β-synucleins in human lipidoses
Suzuki, K., Iseki, E., Togo, T., Yamaguchi, A., Katsuse, O., Katsuyama, K., Kanzaki, S., Shiozaki, K., Kawanishi, C., Yamashita, S., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0264-z · Cited by 83
Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
Huang, X., Auinger, P., Eberly, S. W., Oakes, D., Schwarzschild, M. A., Ascherio, A., Mailman, R. B., Chen, H., & for the Parkinson Study Group DATATOP Investigators (2011) · PLoS ONE · doi:10.1371/journal.pone.0022854 · Cited by 82
Golovko, M. Y., Rosenberger, T. A., Feddersen, S., Færgeman, N. J., & Murphy, E. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04357.x · Cited by 80
Hadjiconstantinou, M., Mariani, A. P., & Neff, N. H. (1989) · Brain Research · doi:10.1016/0006-8993(89)90373-9 · Cited by 79
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Kim, M. J., Jeon, S., Burbulla, L. F., & Krainc, D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy105 · Cited by 79
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Brain lipidomics: From functional landscape to clinical significance
Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324
Lipid droplets in the nervous system
Ralhan, I., Chang, C.-L., Lippincott-Schwartz, J., & Ioannou, M. S. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202102136 · Cited by 281
“While alterations in lipid homeostasis are well studied in many neuropathologies (Alecu and Bennett, 2019; Chang and Chang, 2017; Karasinska and Hayden, 2011), the appearance and function of lipid droplets in the brain have only recently gained attention.”
BackgroundPlasma membrane integrity in health and disease: significance and therapeutic potential
Dias, C., & Nylandsted, J. (2021) · Cell Discovery · doi:10.1038/s41421-020-00233-2 · Cited by 278
Probiotic Bacillus subtilis protects against α-synuclein aggregation in C. elegans
Goya, M. E., Xue, F., Sampedro-Torres-Quevedo, C., Arnaouteli, S., Riquelme-Dominguez, L., Romanowski, A., Brydon, J., Ball, K. L., Stanley-Wall, N. R., & Doitsidou, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.078 · Cited by 205
“We focused on a specific pathway branch of lipid metabolism, the sphingolipid metabolism pathway, as it has been proposed to modify a-syn pathology in PD (Alecu and Bennett, 2019; Galvagnion, 2017; Lin et al., 2019; Plotegher et al., 2019).”
Background
Metadata
- Authors
- Alecu, I., & Bennett, S. A. L.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-04-11
- Volume
- 13
- Pages
- 328-328
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2938730938
- Cited by
- 258
- References
- 247
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.